The 'Open-Artery Hypothesis': new clinical and pathophysiologic insights

Antonio Abbate1, Giuseppe G L Biondi-Zoccai, Alfonso Baldi

  • 1Institute of Cardiology, Catholic University, Largo A. Gemelli, 8, IT-00168 Rome, Italy. abbatea@yahoo.com

Cardiology
|January 10, 2004
PubMed

Insights

The open-artery hypothesis suggests that restoring blood flow to the heart muscle, even late, benefits patients after myocardial infarction. Current evidence is inconclusive, necessitating further research into late revascularization benefits.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • The open-artery hypothesis posits that maintaining or restoring blood flow in the infarct-related artery after myocardial infarction (MI) confers benefits, even if myocardial salvage is limited.
  • Observational data consistently show adverse effects of permanent artery occlusion and benefits of spontaneous reperfusion, but evidence for late revascularization remains inconclusive.
  • Existing randomized trials are often underpowered, and potential pathophysiological mechanisms for reperfusion benefits require further elucidation.

Purpose of the Study:

  • To evaluate the current evidence supporting the open-artery hypothesis regarding late revascularization after acute myocardial infarction.
  • To highlight the limitations of existing studies, including selection bias in observational data and insufficient sample sizes in randomized trials.
  • To underscore the need for further research to clarify the benefits of late reperfusion in preventing adverse cardiac remodeling and reducing mortality.

Main Methods:

  • Review and synthesis of existing observational studies and randomized controlled trials investigating the impact of infarct-related artery patency on outcomes after acute myocardial infarction.
  • Analysis of potential pathophysiological mechanisms that may explain the benefits of myocardial reperfusion.
  • Identification of limitations in current research methodologies and data.

Main Results:

  • Observational studies suggest a consistent benefit of spontaneous reperfusion and a detrimental effect of permanent artery occlusion.
  • Evidence regarding the benefits of late revascularization (i.e., opening a previously occluded artery after a significant delay) is inconclusive, with conflicting results from small randomized trials.
  • Significant selection biases in observational studies and insufficient statistical power in randomized trials limit definitive conclusions.

Conclusions:

  • The open-artery hypothesis, while biologically plausible and supported by some observational data, remains unproven, particularly concerning late revascularization.
  • Further well-designed, adequately powered randomized trials are essential to definitively establish the benefits of late reperfusion strategies after acute myocardial infarction.
  • Confirming the benefits of late reperfusion could lead to improved management strategies, potentially reducing left ventricular remodeling, morbidity, and mortality.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...